Extendicare Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Extendicare ha aumentado sus beneficios a una tasa media anual de 0.3%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento de 0.3% anual. Los ingresos han ido creciendo a una tasa media de 2.8% al año. La rentabilidad financiera de Extendicare es de 38.7%, y sus márgenes netos son de 2.6%.

Información clave

0.3%

Tasa de crecimiento de los beneficios

1.0%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare	-6.7%
Tasa de crecimiento de los ingresos	2.8%
Rentabilidad financiera	38.7%
Margen neto	2.6%
Próxima actualización de resultados	15 May 2024

Actualizaciones de resultados anteriores recientes

There May Be Underlying Issues With The Quality Of Extendicare's (TSE:EXE) Earnings

Mar 16

Recent updates

There May Be Underlying Issues With The Quality Of Extendicare's (TSE:EXE) Earnings

Mar 16

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Extendicare. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

TSX:EXE Ingresos, gastos y beneficios (CAD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	1,305	34	56
30 Sep 23	1,265	18	55
30 Jun 23	1,252	1	53
31 Mar 23	1,241	3	52
31 Dec 22	1,222	-5	51
30 Sep 22	1,217	-1	55
30 Jun 22	1,193	6	51
31 Mar 22	1,178	4	53
31 Dec 21	1,167	8	52
30 Sep 21	1,114	27	49
30 Jun 21	1,126	59	51
31 Mar 21	1,127	49	47
31 Dec 20	1,104	42	45
30 Sep 20	1,141	31	42
30 Jun 20	1,127	2	41
31 Mar 20	1,129	15	41
31 Dec 19	1,132	15	41
30 Sep 19	1,130	1	41
30 Jun 19	1,127	4	42
31 Mar 19	1,123	6	41
31 Dec 18	1,120	8	40
30 Sep 18	1,113	27	37
30 Jun 18	1,106	26	37
31 Mar 18	1,100	30	37
31 Dec 17	1,097	32	38
30 Sep 17	1,093	35	40
30 Jun 17	1,088	38	38
31 Mar 17	1,075	38	37
31 Dec 16	1,061	31	37
30 Sep 16	1,046	25	38
30 Jun 16	1,032	27	38
31 Mar 16	1,005	21	38
31 Dec 15	943	24	36
30 Sep 15	894	24	33
30 Jun 15	848	16	32
31 Mar 15	815	14	33
31 Dec 14	816	11	33
30 Sep 14	-118	2	7
30 Jun 14	183	4	16
31 Mar 14	480	9	26
31 Dec 13	784	10	37
30 Sep 13	2,002	26	74
30 Jun 13	1,992	15	74

Ingresos de calidad: EXE tiene un alto nivel de ganancias no monetarias.

Margen de beneficios creciente: EXE pasó a ser rentable.

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de EXE han crecido un 0.3% al año en los últimos 5 años.

Acelerando crecimiento: EXE ha pasado a ser rentable en el último año, lo que dificulta la comparación de la tasa de crecimiento de los beneficios con su promedio de 5 años.

Beneficios vs. Industria: EXE ha pasado a ser rentable en el último año, lo que es difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Healthcare (6.3%).

Rentabilidad financiera

Alta ROE: Aunque la rentabilidad financiera (38.65%) de EXE es alta, esta métrica está sesgada debido a su elevado nivel de endeudamiento.

Extendicare Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Información clave

Actualizaciones de resultados anteriores recientes

Extendicare Inc. to Report Q1, 2024 Results on May 15, 2024

There May Be Underlying Issues With The Quality Of Extendicare's (TSE:EXE) Earnings

Full year 2023 earnings released: EPS: CA$0.40 (vs CA$0.051 loss in FY 2022)

Extendicare Inc. to Report Q4, 2023 Results on Mar 07, 2024

Third quarter 2023 earnings released: EPS: CA$0.14 (vs CA$0.049 loss in 3Q 2022)

Extendicare Inc. to Report Q3, 2023 Results on Nov 09, 2023

Recent updates

Upcoming dividend of CA$0.04 per share

Extendicare Inc., Annual General Meeting, May 23, 2024

Dividend of CA$0.04 announced

Extendicare Inc. Declares Cash Dividend for the Month of April 2024, Payable on May 15, 2024

Extendicare Inc. to Report Q1, 2024 Results on May 15, 2024

CEO, President & Director exercised options to buy CA$450k worth of stock.

Upcoming dividend of CA$0.04 per share

There May Be Underlying Issues With The Quality Of Extendicare's (TSE:EXE) Earnings

Price target increased by 10% to CA$8.00

Dividend of CA$0.04 announced

Full year 2023 earnings released: EPS: CA$0.40 (vs CA$0.051 loss in FY 2022)

Extendicare Inc. Declares Cash Dividend for the Month of March 2024, Payable on April 15, 2024

Upcoming dividend of CA$0.04 per share

Dividend of CA$0.04 announced

Extendicare Inc. Declares Cash Dividend for the Month of February 2024, Payable on March 15, 2024

Upcoming dividend of CA$0.04 per share at 6.7% yield

Extendicare Inc. to Report Q4, 2023 Results on Mar 07, 2024

Extendicare Inc. Declares Cash Dividend for the Month of December 2023, Payable on January 15, 2024

Independent Director recently bought CA$99k worth of stock

Upcoming dividend of CA$0.04 per share at 7.4% yield

Extendicare Inc. Declares Cash Dividend for the Month of November 2023, Payable on December 15, 2023

Third quarter 2023 earnings released: EPS: CA$0.14 (vs CA$0.049 loss in 3Q 2022)

Upcoming dividend of CA$0.04 per share at 7.9% yield

Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of October 2023, Payable on November 15, 2023

Extendicare Inc. to Report Q3, 2023 Results on Nov 09, 2023

Upcoming dividend of CA$0.04 per share at 7.8% yield

Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.04

Extendicare Inc. Announces Cash Dividend for the September 2023, Payable on October 16, 2023

Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04

Upcoming dividend of CA$0.04 per share at 7.4% yield

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: CA$0.02 (vs CA$0.039 in 2Q 2022)

Extendicare Inc. Declares Cash Dividend for the Month of August 2023, Payable on September 15, 2023

Extendicare Inc. (TSX:EXE) completed the acquisition of a 15 percent stake in a Portfolio of 24 Long Term Care Homes from Revera Inc. and Axium Infrastructure Inc.

Upcoming dividend of CA$0.04 per share at 6.5% yield

Extendicare's (TSE:EXE) Dividend Will Be CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of July 2023, Payable on August 15, 2023

Extendicare Inc. to Report Q2, 2023 Results on Aug 10, 2023

Upcoming dividend of CA$0.04 per share at 6.7% yield

Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of June 2023, Payable on July 17, 2023

Insufficient new directors

Independent Director recently bought CA$108k worth of stock

Upcoming dividend of CA$0.04 per share at 6.6% yield

Extendicare (TSE:EXE) Has Affirmed Its Dividend Of CA$0.04

Senior Vice President of ParaMed & CTO recently bought CA$206k worth of stock

Is Extendicare (TSE:EXE) Using Too Much Debt?

First quarter 2023 earnings released: EPS: CA$0.14 (vs CA$0.045 in 1Q 2022)

Upcoming dividend of CA$0.04 per share at 7.4% yield

CEO, President & Director recently bought CA$189k worth of stock

Upcoming dividend of CA$0.04 per share at 7.9% yield

CEO, President & Director exercised options to buy CA$258k worth of stock.

Full year 2022 earnings released: CA$0.051 loss per share (vs CA$0.10 profit in FY 2021)

Upcoming dividend of CA$0.04 per share at 7.1% yield

Extendicare Inc. Declares Dividend for the Month of February 2023, Payable on March 15, 2023

Upcoming dividend of CA$0.04 per share

Extendicare Inc. to Report Q4, 2022 Results on Mar 02, 2023

Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of January 2023, Payable on February 15, 2023

Upcoming dividend of CA$0.04 per share

Extendicare Inc. Declares Cash Dividend for the Month of December 2022, Payable on January 16, 2023

Independent Director recently bought CA$151k worth of stock

Upcoming dividend of CA$0.04 per share

Third quarter 2022 earnings released: CA$0.049 loss per share (vs CA$0.031 profit in 3Q 2021)

Third quarter 2022 earnings released: CA$0.041 loss per share (vs CA$0.027 profit in 3Q 2021)

Saskatchewan Health Authority acquired Ownership and operations of five Saskatchewan LTC homes from Extendicare Inc. (TSX : EXE) for CAD 13.1 million.

Extendicare Inc. Declares Dividend for the Month of November 2022, Payable on December 15, 2022

Upcoming dividend of CA$0.04 per share

Desglose de ingresos y gastos
Beta